02.19.26 -- STREAM Edition: Regulatory Guidance For Cleaning And Disinfecting

Uncover how pharma companies can select tailored pre-filled syringes for biologics and biosimilars by aligning drug delivery needs with specialized containers and analytical services.

Testing IV bags in compliance with Annex 1 guidelines requires a robust technology strategy to ensure product quality and patient safety. Learn how to deploy and validate technologies for IV bag CCI.

The buzz around Pharma 4.0 and paperless management systems is growing, but how can you apply it to the visual inspection of parenteral drugs? The Identifier Software is your solution.

Discover how Parvulet addresses the needs of diverse patient populations by improving patient adherence, enhancing dosing accuracy, and providing a more comfortable medication experience.

In this segment from the Pharmaceutical Online Live event, “Contamination Control Strategies For Drug Manufacturers,” panelists discuss evolving regulatory guidance for cleaning and disinfection, including revisions to PDA Technical Report 70 and USP 1072, and a new forthcoming technical report on material transfer.

Rigid, one-time transformations can’t keep up with today’s disruptions. Continuous Transformation offers an iterative, agile approach that drives resilience and sustained progress.